Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

692 Press Releases
DateTitleCompany
22 Jun 15 Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline Pfizer,
Published by
PharmiWeb.com
22 Jun 15 Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline Pfizer Inc.,
Published by
Business Wire
15 Jun 15 Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China Pfizer Inc.,
Published by
Business Wire
12 Jun 15 Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder Pfizer ,
Published by
PharmiWeb.com
11 Jun 15 Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder Pfizer Inc,
Published by
Business Wire
10 Jun 15 Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015) Pfizer,
Published by
PharmiWeb.com
09 Jun 15 Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology Pfizer ,
Published by
PharmiWeb.com
08 Jun 15 Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology Pfizer Inc.,
Published by
Business Wire
04 Jun 15 Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign Pfizer Inc.,
Published by
Business Wire
30 May 15 Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+ HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy Pfizer Inc.,
Published by
Business Wire
29 May 15 Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM) A Rare Progressive Lung Disease Pfizer Inc.,
Published by
Business Wire
28 May 15 Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health Pfizer Inc.,
Published by
Business Wire
28 May 15 Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer Pfizer Inc.,
Published by
Business Wire
21 May 15 America's Most-Preferred Multivitamin Brand Launches New Centrum® MultiGummies Pfizer Inc.,
Published by
Business Wire
19 May 15 Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations Pfizer Inc.,
Published by
Business Wire
14 May 15 Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira Pfizer Inc.,
Published by
Business Wire
14 May 15 Marc Tessier-Lavigne Ph.D. to Leave Pfizer Board of Directors Pfizer Inc.,
Published by
Business Wire
14 May 15 Merck and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer,
Published by
Business Wire
16 Apr 15 Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders Pfizer Inc.,
Published by
Business Wire
06 May 15 Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat Pfizer Inc.,
Published by
Business Wire
16 Apr 15 Pfizer Launches 2014 Integrated Annual Review Pfizer Inc.,
Published by
Business Wire
20 Apr 15 Global Strategic Partners Merck KGaA Darmstadt Germany and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
21 Apr 15 Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia Pfizer,
Published by
Business Wire
21 Apr 15 Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
30 Mar 15 Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer Inflammation and Immunology Research Unit Pfizer Inc.,
Published by
Business Wire
14 May 15 Merck KGaA Darmstadt Germany and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer Inc. and Merck KGaA, Darmstadt, Germany,
Published by
Business Wire
07 May 15 Summer of TAG Educational Tour to Promote Allergy Awareness in Vancouver and Edmonton Pfizer Canada Inc.,
Published by
PR Newswire
15 Apr 15 Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+ HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy Pfizer Inc.,
Published by
Business Wire
09 Apr 15 Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research Pfizer Inc.,
Published by
Business Wire
06 Apr 15 Kathrin U. Jansen Ph.D. to Lead Pfizer’s Vaccine Research and Development Unit Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.